SOLICITATION NOTICE
68 -- Diagnostic Substances
- Notice Date
- 8/27/2002
- Notice Type
- Solicitation Notice
- Contracting Office
- Department of Health and Human Services, Center for Disease Control and Prevention, Procurement and Grants Office (Atlanta), 2920 Brandywine Road, Room 3000, Atlanta, GA, 30341-4146
- ZIP Code
- 30341-4146
- Solicitation Number
- 037R302
- Response Due
- 9/11/2002
- Archive Date
- 9/26/2002
- Point of Contact
- Lenore Mickle, Contract Specialist, Phone (770)488-2606, Fax (770)488-2670,
- E-Mail Address
-
LMickle@CDC.GOV
- Description
- The Centers for Disease Control and Prevention intends to purchase Recombinant Biotinylated and Monoclonal Antibodies from Biosite, 11030 Roselle St., San Diego, CA 92121. The Government intends to purchase the following: 1) Cat# P0202 Anti-B Anthracis Antibody (Phage Displayed) IIT005.1.C.11, 50 EA; and, 2) Cat# P0200 Anti-B Anthracis Antibody (Phage Displayed) IIT005.1.C.11.1 - Biotin, 50 EA. The Government intends to evaluate offers and award a contract without discussions with Offerors providing the requested product. Therefore, the initial offer should contain the offeror's best terms from a technical and price standpoint. The North American Industry Classification (NAICS) Code is 325413 and the Size Standard is 500 employees for this requirement. This requirement is a not small business set-aside. Interested vendors capable of furnishing the government with the products in this synopsis should submit two (2) copies of a quotation to the below address. The quotation shall include the itemized price, prompt payment terms, the F.O.B. Point (Destination or Origin), Taxpayer Identification Number (TNN), Dun & Bradstreet Number (DUNs), and descriptive literature of the product quoted. The quotation must reference Solicitation number 037R302. Quotations will be due fifteen (15) calendar days from the publication date of this synopsis or 9/11/02, by 8:30 a.m. local time, whichever is later. All responsible sources may submit a quotation, which if timely received, shall be considered by the agency. Quotations must be submitted in writing to the Centers for Disease Control and Prevention, 2920 Brandywine Road, Atlanta, GA 30341, Attention: Lenore Mickle. Email quotations will only be accepted if dated and signed by an authorized company representative to: Lmickle@cdc.gov. Biosite is the only source known to the government that can provide substances with the above characteristics. However, if any interested party believes it can meet the above requirements, it may submit a statement of capabilities. The capability statement and any other furnished information must be in writing and must contain material in sufficient detail to allow CDC to determine if the party can fully meet the requirements herein. This action is pursuant to 41 USC 253(1) and under the authority of FAR 6.302-1. The requirement will be procured as a commercial item in accordance with FAR Part 12.102(c) under the test program. A determination by the Government not to compete this proposed requirement based on responses to this notice is solely within the discretion of the Government. THIS IS A COMBINED SYNOPSIS/SOLICITATION FOR COMMERCIAL ITEMS PREPARED IN ACCORDANCE WITH THE FORMAT IN SUBPART 12.6, AS SUPPLEMENTED WITH ADDITIONAL INFORMATION INCLUDED IN THIS NOTICE. THIS ANNOUNCEMENT CONSTITUTES THE ONLY SOLICITATION; QUOTES ARE BEING REQUESTED AND A WRITTEN SOLICITATION WILL NOT BE ISSUED. The following provisions apply to this acquisition; 52.212-1 Instructions to Offerors - Commercials Items (MAR 2000) applies to this acquisition; 52.212-2, Evaluation - Commercial Items (JAN 1999); the evaluation criteria stated in paragraph (a) of this provision are as follows: (1) technical capability of the proposed system to meet the requirements stated herein, and (2) price. The clause 52.212-4, Contract Terms & Conditions - Commercial Items (MAY 1999) applies to this acquisition. The following FAR Clauses are hereby added to this clause: 52.247-35 F.O.B. Destination; The clause at 52.212-5 - Contract Terms and Conditions Required to Implement Statutes or Executive Orders - Commercial Items applies to this acquisition. The following clauses listed in paragraph (b) of 52.212-5 apply to this acquisition: (1), (3), (5), (7), (9), (11), (12), (14), (15), (17), (18), (20) and (24). OFFERORS SHALL INCLUDE A COMPLETED COPY OF THE PROVISION AT 52.212-3, OFFERORS REPRESENTATIONS AND CERTIFICATIONS - COMMERCIAL ITEMS, WITH YOUR QUOTE. The best way to complete this certification is to download the FAR Clauses (Volume II) at: http://www.arnet.gov/far, print out the clause 52.212-3, Offeror Representation and Certification, and fill in the appropriate blanks. This procurement is not set-aside for small business. Quotes will be due 15 days from date of publication of this synopsis, by 8:30 AM EST at the Centers for Disease Control and Prevention; Facilities and Construction Management Branch; Attn: Lenore Mickle; 2920 Brandywine Road, Room 3000, Atlanta, GA 30341. Facsimile quotes will be accepted at 770-488-2847 or 2819. RFQ# 037R302. Attn: Lenore Mickle, shall be clearly marked on the envelope and/or facsimile cover page. All responsible sources that can meet the above requirement may submit a quote, which will be considered by the Agency.*****.
- Web Link
-
Link to FedBizOpps document.
(http://www.eps.gov/spg/HHS/CDCP/PGOA/037R302/listing.html)
- Record
- SN00151622-F 20020829/020827221241 (fbodaily.com)
- Source
-
FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |